1. Anticoagulation and Thrombosis Management

2. Comparative PK/PD of NOACs

3. NOACs in Prevention of AF-related Stroke

4. NOAC SPAF Trials

5. NOAC Trials Baseline Characteristics

9. NOACs in Venous Thromboembolism

10. Acute VTE Treatment Trials

11. RE-COVER II Study Design

13. EINSTEIN DVT/PE Study Designs

17. AMPLIFY Study Design

20. Hokusai-VTE Results

21. Recurrent VTE in Extension VTE Trials

22. Major Bleeding in Extension VTE Trials

23. EINSTEIN-EXT Study Design

25. AMPLIFY-EXT Study Design

26. AMPLIFY-EXT Results

27. NOACs in ACS

28. Rationale for Use of Oral Anticoagulation Post-Myocardial Infarction

29. APPRAISE-2 Efficacy and Safety Results

32. ATLAS-2 Mortality Benefit With Very Low-Dose Rivaroxaban in Patients With STEMI

33. Abbreviations

34. Abbreviations (cont)

35. References

36. References (cont)

37. References (cont)

38. References (cont)

39. References (cont)